Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the use of existing CAR-T therapies. In its January 19 notification letters, the agency stressed that the potential risk applies to all…
#fda #gileadsciencesincs #johnsonjohnsonjnj #novartisagnvs #bristol #breyanzi #yescarta #tecartus #novartis #astrazenecaplcazn